🇺🇸 FDA
Pipeline program

TAK-981

TAK-981-1501

Phase 2 small_molecule terminated

Quick answer

TAK-981 for Lymphoma, Non-Hodgkin is a Phase 2 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Lymphoma, Non-Hodgkin
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials